Cleveland BioLabs financials at a glance
| Year | Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2004 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.71M | $2.02M | $4.71M | $14.35M | $15.33M | $8.79M | $3.57M | $8.49M | $3.70M | $2.71M | $3.52M | $1.95M | $1.14M | $1.11M | $0.26M | $0.00M | $0.64M | $1.14M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | -179.68% | 0.10% | -5.28% | -159.25% | 0.00% | -124.08% | -160.79% | -163.76% | -84.63% | -159.11% | -217.97% | -48.77% | -162.82% | 0.00% | 0.00% | -131.84% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | -44.49% | -70.03% | -285.60% | 0.00% | -265.91% | 0.00% | 0.00% | -180.65% | -287.46% | 0.00% | -212.03% | 0.00% | 0.00% | 0.00% | -218.45% |
| EPS | Earnings Per Share |
|
$0.00 | |||||||||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0.59m | 0.61m | 0.68m | 1.01m | 1.45m | 1.78m | 2.17m | 2.26m | 2.86m | 10.72m | 10.99m | 11.28m | 11.3m | 11.3m | 13.34m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-6.65M | $-16.61M | $-12.12M | $-4.24M | $-5.90M | $-16.91M | $-20.65M | $-23.10M | $-14.46M | $-12.08M | $-5.04M | $-6.61M | $-4.61M | $-2.66M | $-2.37M | $0.00M | $-0.21M | $-1.73M |
| FCF | Free Cash Flow |
|
$-6.84M | $-17.60M | $-12.34M | $-4.38M | $-6.37M | $-17.57M | $-20.83M | $-23.24M | $-14.48M | $-12.10M | $-5.05M | $0.00M | $-4.64M | $0.00M | $0.00M | $0.00M | $-0.24M | $-2.06M |
| FCFS | Free Cash Flow Per Share |
|
$-15.76 | $-30.89 | $-20.66 | $-6.77 | $-5.05 | $-10.99 | $-11.14 | $-10.33 | $-5.36 | $-1.71 | $-0.46 | $-0.59 | $-0.41 | $-0.24 | $-0.19 | $0.00 | $-1.02 | $-6.83 |